BRIA IMT SV-BR-1-GM A Phase 3, randomized open label study comparing the Bria-IMT regimen in combination with CPI vs MD choice in metastatic breast cancer



Mary Beth Wilwerding, RN Admin@NEcancertrials.com



Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*

Email*

Phone*

Message*